Search by Drug Name or NDC

    NDC 00904-6779-61 Rosuvastatin Calcium 10 mg/1 Details

    Rosuvastatin Calcium 10 mg/1

    Rosuvastatin Calcium is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is ROSUVASTATIN CALCIUM.

    Product Information

    NDC 00904-6779
    Product ID 0904-6779_49bddf59-d42a-40d7-80f2-1f5dcd1db8dc
    Associated GPIs 39400060100310
    GCN Sequence Number 051784
    GCN Sequence Number Description rosuvastatin calcium TABLET 10 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 19153
    HICL Sequence Number 025009
    HICL Sequence Number Description ROSUVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name Rosuvastatin Calcium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Rosuvastatin Calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name ROSUVASTATIN CALCIUM
    Labeler Name Major Pharmaceuticals
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201619
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-6779-61 (00904677961)

    NDC Package Code 0904-6779-61
    Billing NDC 00904677961
    Package 100 BLISTER PACK in 1 CARTON (0904-6779-61) / 1 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2016-10-31
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04891
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ROSUVASTATIN CALCIUM 10 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis